Chefaa raises USD 5.3 mn from global investors: Egypt-based pharma delivery platform Chefaa raised USD 5.25 mn from a number of international investors, it said in a statement (pdf) yesterday. The funding round was co-led by South African VC Newtown Partners, Japan-based Global Brain and M3, US investor GMS Capital Partners, and Nigeria’s Verod-Kepple Africa Ventures,

Where’s the money going? The company will use the funds to “scale all models designed to digitize the supply chain and empower industry stakeholders.”

About Chefaa: Founded in 2017, the woman-led startup wants to be a “one-stop-health solution for an end-to-end healthcare experience.” The platform facilitates the process of ordering, scheduling, and refilling recurring prescriptions. It currently operates across Egypt and eight Saudi cities, connecting over 1 mn users to 1.1k pharmacies.

Background: Investors Newtown Partners, Global Brain, and GMS Capital are no strangers to Chefaa, leading a funding round last year. The company closed a seven-figure USD pre-series A round in 2020, after raising a six-figure USD sum from Flat6Labs and 500 Startups in a 2019 seed round.

Tags: